about
sameAs
Prevention of infections during primary immunodeficiencyTwo episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavirStaphylococcus aureus Bloodstream Infection and Endocarditis--A Prospective Cohort StudyLung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working Group.[Long-term immunologic response in HIV-infected patients with CD4 cell counts </= 50/mm3 when initiating protease inhibitor therapy]Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study GroupRise of CC398 lineage of Staphylococcus aureus among Infective endocarditis isolates revealed by two consecutive population-based studies in FranceEfficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in AfricaMulticytokine detection improves latent tuberculosis diagnosis in health care workersSymptomatic and Asymptomatic Neurological Complications of Infective Endocarditis: Impact on Surgical Management and Prognosis.Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study.Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: impact of antiretroviral therapy and immunovirological status.Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapy.Fulminant varicella hepatitis in a human immunodeficiency virus infected patient: case report and review of the literature.One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study.Interactions between cytotoxic chemotherapy and antiretroviral treatment in human immunodeficiency virus-infected patients with lung cancer.Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients: a nested case-control study.Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, oFDG-PET in a myocardial tuberculoma.Simple Scoring System to Predict In-Hospital Mortality After Surgery for Infective Endocarditis.Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers.Zika virus infections in three travellers returning from South America and the Caribbean respectively, to Montpellier, France, December 2015 to January 2016.Impact of T cell activation, HIV replication and hepatitis C virus infection on neutrophil CD64 expression.Evolution of renal function in African patients initiating second-line antiretroviral treatment: findings from the ANRS 12169 2LADY trial.Chest Low-Dose Computed Tomography for Early Lung Cancer Diagnosis as an Opportunity to Diagnose Vertebral Fractures in HIV-Infected Smokers, an ANRS EP48 HIV CHEST Substudy.Investigation of pre-XDR Beijing Mycobacterium tuberculosis transmission to a healthcare worker in France, 2016.Incidence of infectious morbidity events after second-line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon.Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course.[Paradoxical aggravation of tuberculosis after antiretroviral therapy in HIV-infected patients].[Intermittent fever of infectious origin].Staphylococcus aureus infective endocarditis versus bacteremia strains: Subtle genetic differences at stake.Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia.Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices.Diagnosing pelvic osteomyelitis beneath pressure ulcers in spinal cord injured patients: a prospective study.[Living Lab MACVIA. Chronic infectious diseases].Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort.Acquired hemophilia: a rare complication of Sjögren's syndrome.
P50
Q27008430-BD43B393-5DE5-47CB-9092-0320A258382EQ28371050-5F6D4E60-F86B-461B-91AE-222E1EB815FFQ28547587-888A13C5-C599-4E13-B616-2EB8C50FE9D5Q30248826-3906582E-3A50-4240-9A33-7874F9F4E08BQ32152368-7FF8959B-A484-411E-A20D-305A567C64A8Q33794374-C89B0689-92DB-44B0-998D-5DACD0221235Q33981058-A66787F7-72BE-460E-8A61-58D8B0772A50Q34525175-DFCC8E0A-514F-4453-8FAD-207E8FD78F8FQ35853812-16FC8113-08D7-42BF-B07A-97A6134166B1Q35943027-16BE5D46-EC17-4607-B869-2B78B6415F3DQ36072736-04A38B52-F662-4728-A0DC-EA829658EB5DQ36109018-68CDB006-9D9E-4513-9E56-42A231F16691Q36300347-26255942-C9A6-4464-950F-0355641BCC32Q36496736-B846D0FE-7903-43D2-A5D1-20488C2E7BE7Q36606610-C6AC056B-4D98-4808-BBDD-DB6DBD65F6EBQ37034835-7964B2AE-A8F8-4301-B470-0A5FBC45E27DQ37701216-8F41EE8B-EAEC-4A3E-9D82-224CE03030E3Q38413905-F8CDF17F-362B-44B6-9513-2904A46E2F4BQ38752758-5397B007-4BE1-4128-AC18-569CDA18BFA2Q38919921-9E62F192-6FB3-46E1-BE81-7FE71EB24E08Q39018796-D07B384E-3BB7-4EBB-AC5F-A4135B8CC3DAQ39196660-65970798-7281-4860-8D30-EF40CD71D878Q39206781-F08C900B-091F-457E-9E20-BDA6CAE1E324Q39214994-8CE2164F-B9A3-41A1-9C45-A97341213D26Q39270283-05A87FE5-12BA-491F-9204-706B5A5A6463Q39321013-DC5E5319-D08D-41D1-AEF6-225C239193E1Q39523245-7CF78FC1-FB00-4591-91E1-D688764D7DA9Q40137781-A40A1350-82E5-45BD-A644-CABFEFB96AB5Q40486177-F960570A-C6C1-451F-98D9-86A908D20A7BQ40540273-7A9DCF17-DF7B-441B-A829-4B31BB156F0FQ40572757-100A710C-F2F2-4270-910E-AE5D6D50FE7DQ40585987-4F6D97C3-84DC-4FEC-93F8-2C493721C5BEQ40595335-7C6A8423-3DF2-4458-931F-93336D74ADAFQ40633461-9834EDEE-C295-4757-8489-AE87FA298847Q40777327-4C40F57A-DF5D-4FCD-A040-9F225EC28808Q40864933-1028F21F-0784-4BB9-9A0B-73BFFC92E1CDQ40889428-0CD975FF-EEAD-4FB7-B0D1-9EB9B4C72544Q40945387-E72D5DD5-85A0-4089-AC8D-04E029324642Q41093607-2B974987-7B2D-4407-8750-53C7910F1AA5Q41206675-93CF7FF6-91C6-4F35-9559-613C7D887C35
P50
description
researcher ORCID ID = 0000-0002-9529-2792
@en
wetenschapper
@nl
name
Vincent Le Moing
@ast
Vincent Le Moing
@en
Vincent Le Moing
@es
Vincent Le Moing
@nl
type
label
Vincent Le Moing
@ast
Vincent Le Moing
@en
Vincent Le Moing
@es
Vincent Le Moing
@nl
prefLabel
Vincent Le Moing
@ast
Vincent Le Moing
@en
Vincent Le Moing
@es
Vincent Le Moing
@nl
P106
P31
P496
0000-0002-9529-2792